Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2004-10-11
pubmed:abstractText
Oligodendroglial neoplasms with chromosome 1p deletion are chemosensitive, and stratified adjuvant therapies have been proposed on the basis of 1p status. In this study, we evaluated expression of hypoxia-related factors and its influence on survival in oligodendroglial brain tumors with chromosome 1p aberrations.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6567-71
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15475445-Adult, pubmed-meshheading:15475445-Brain Neoplasms, pubmed-meshheading:15475445-Carbonic Anhydrases, pubmed-meshheading:15475445-Chemotherapy, Adjuvant, pubmed-meshheading:15475445-Chromosome Deletion, pubmed-meshheading:15475445-Chromosomes, Human, Pair 1, pubmed-meshheading:15475445-DNA-Binding Proteins, pubmed-meshheading:15475445-Female, pubmed-meshheading:15475445-Humans, pubmed-meshheading:15475445-Hypoxia-Inducible Factor 1, pubmed-meshheading:15475445-Hypoxia-Inducible Factor 1, alpha Subunit, pubmed-meshheading:15475445-Immunohistochemistry, pubmed-meshheading:15475445-In Situ Hybridization, pubmed-meshheading:15475445-In Situ Hybridization, Fluorescence, pubmed-meshheading:15475445-Male, pubmed-meshheading:15475445-Middle Aged, pubmed-meshheading:15475445-Neoplasm Recurrence, Local, pubmed-meshheading:15475445-Nuclear Proteins, pubmed-meshheading:15475445-Oligodendroglioma, pubmed-meshheading:15475445-RNA, Messenger, pubmed-meshheading:15475445-Survival Analysis, pubmed-meshheading:15475445-Transcription Factors, pubmed-meshheading:15475445-Vascular Endothelial Growth Factor A
pubmed:year
2004
pubmed:articleTitle
Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implications.
pubmed:affiliation
Institute of Neurology, Medical University Vienna, Vienna, Austria.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't